Methods for microsphere production

Overview

Information

Number
6224794
Application
09/305857
Filing date
05/05/1999
Issue date
05/01/2001
Inventor(s)
Brian G. Amsden, Richard T. Liggins
US Classification
264/4.1; 264/4.3; 264/4.33; 264/4.6; 427/213.3; 427/213.31; 427/213.35; 427/213.36; 428/402.2; 428/402.21
View at USPTO

Citations

California institute of Technology (2)
Liquid Gas Co. (1)
Suzuki Yushi Industrial Co. (1)
Osaka Gas (1)
Mitsubishi Pharma (1)
LI, WEN HUI (1)
Connaught Laboratories (1)
P. H. Glatfelter (1)
STOVER, HARALD D.H. (1)
LI, KAI (1)
Vanderbilt University (1)
DIAMOND TECHNOLOGY PARTNERSHIP (1)
Fujimoro Kogyo Co. (1)

Abstract

Abstract

A process for forming microspheres that includes passing a first composition containing polymer and solvent through an orifice and directly into a second composition containing water and a microsphere-stabilizing agent, under at least one of conditions (a) and (b), wherein (a) the first composition flows through a first conduit along a first path and exits the first conduit at the orifice, the second composition flows through a second conduit along a second path in an upstream to downstream direction, the first conduit is connected to the second conduit and terminates at the orifice, the first and second paths being orientated at an angle .theta. relative to each other, wherein 0.degree.<.theta.<180.degree.; (b) the first composition being at a first temperature and including a solvent having a boiling point, the second composition being at a second temperature, the boiling point of the solvent being less than the second temperature; and forming a composition including water and microspheres, the microspheres being formed, at least in part, by the polymer. Such microspheres are suitable for use in the delivery of bioactive agents for animal, aquarian and human use, as a means of radio-imaging tissue, as well as for the controlled release of agro-chemicals.

Assignees with Similar Patents

Referenced by

Boston Scientific (35)
Ecole Polytechnique Federale de Lausanne (18)
École polytechnique fédérale de lausanne (9)
Biosphere Medical, (5)
Board of Trustees of the University of Illinois, The (5)
Abbott Cardiovascular Systems (5)
anokion (5)
Novo Nordisk A/S (4)
Vascular Therapies, (4)
University of Utah (3)
Chitogenics (3)
Solubest (2)
Scimed Life Systems (2)
Alkermes (2)
University of Chicago (2)
abott cardiovascular systems (1)
stryker european operations (1)
Celgene (1)
MicroFab Technologies (1)
STERN, MOSHE (1)
C. EN. (1)
TAIWAN BIOTECH CO. (1)
NA (1)
Asahi Glass (1)
École polytechnique fédérale de lausanna (1)
EVONIK CORPORATION (1)
Merit Medical Systems (1)
Empire Technology Development (1)
HELLEBORE, LLC. (1)
Hydromer (1)
immusoft (1)
Oakwood Laboratories L.L.C. (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
264 4.1 Emerging Average Seminal Medium Average 27.9
264 4.3 Declining Average Average Medium Average 33.5
264 4.33 Stable Average Seminal Medium Average 39.0
264 4.6 Declining Average Average Medium Average 33.3
427 213.3 Stable Average Seminal Medium High Average 36.6
427 213.31 Stable Average Seminal Medium Average 32.0
427 213.35 Declining Average Average Medium Average 26.9
427 213.36 Declining Average Average Medium Average 37.9
428 402.2 Stable Average Average Medium Average 34.8
428 402.21 Stable Average Average Medium Average 41.7